Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition. The second article, “ Additives and Processing Aids in Pharmaceutical Excipients ...

Please provide your email address to receive an email when new articles are posted on . Concomitant medication burden is associated with antifibrotic medication intolerance among patients with ...

Pathological evaluations of the prostate variably reveal incidental prostate cancer in 24–51% of patients with muscle-invasive bladder cancer (MIBC) undergoing radical cystoprostatectomy (RCP) The ...

Please provide your email address to receive an email when new articles are posted on . Concomitant use of common medications did not significantly affect treatment efficacy or safety during UC ...

Clinical trials are central to modern medicine, meticulously designed to evaluate the safety and efficacy of new drugs and treatments. However, the carefully controlled environment of a clinical trial ...

PURPOSE: Temozolomide is a novel oral alkylating agent with demonstrated efficacy as second-line therapy for patients with recurrent anaplastic astrocytoma and glioblastoma multiforme (GBM). This ...

Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, ...